跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 126,872 条关于
“dual HIF-1/2 inhibitors”
全部
126,872
临床试验
85,679
药物
15,400
机构
2,491
资讯
23,302
5个月前
Novel Dual HIF-1/2 Inhibitors Achieve Complete Tumor Remission in Combination with Immunotherapy
去年
Novel HIF-2α Inhibitor Casdatifan Shows Promise in Advanced Kidney Cancer Phase 1 Trial
上个月
Jeil Pharmaceutical's Dual SGLT-1/2 Inhibitor JP-2266 Shows Significant HbA1c Reduction in Phase 2 Diabetes Trial
11个月前
Hanmi Pharmaceutical's Dual EZH1/2 Inhibitor Shows Promising Antitumor Activity in Phase 1 Trial
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
11个月前
Taiho Pharmaceutical Exercises Option for Casdatifan HIF-2α Inhibitor in Asia-Pacific Territories
8个月前
Rani Therapeutics Launches Phase 1 Trial of Oral GLP-1/GLP-2 Dual Agonist RT-114 for Obesity Treatment
去年
Rani Therapeutics Achieves Bioequivalence with Oral GLP-1/GLP-2 Dual Agonist for Obesity Treatment
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
9个月前
SGLT-2 Inhibitors and GLP-1 Agonists Show Promise in Slowing Frailty Progression in Older Diabetic Adults
第 1 页,共 2331 页
上一页
下一页